Freya Biosciences Aps
Clinical trials sponsored by Freya Biosciences Aps, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a vaginal bacteria capsule boost IVF success? Results expected Oct 2026 (estimated)
- New bacterial vaginosis treatment aims to rebalance vaginal flora Results expected Mar 2027 (estimated)
-
Can a vaginal bacteria capsule boost IVF success?
Disease control Recruiting nowThis study tests a new treatment called FB301, a capsule containing beneficial bacteria, for women with an imbalance of vaginal bacteria who have had a failed frozen embryo transfer (IVF). Thirty women aged 18-40 will receive FB301 or a placebo during a mock IVF cycle, with some …
Phase 2 • Sponsor: Freya Biosciences ApS • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New bacterial vaginosis treatment aims to rebalance vaginal flora
Disease control Recruiting nowThis study tests a new treatment called FB301 in 120 women aged 18-45 with bacterial vaginosis (BV). Before FB301, some women will receive an antibiotic or a vaginal wash to see if that helps restore healthy bacteria. The goal is to improve the balance of good bacteria in the vag…
Phase 2 • Sponsor: Freya Biosciences ApS • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC